Lack of genetic evidence that fatty liver disease predisposes to COVID-19

被引：31
作者：
Valenti, Luca [1 ,2 ]
Jamialahmadi, Oveis [3 ]
Romeo, Stefano [3 ,4 ,5 ]
机构：
[1] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy
[2] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Transfus Med & Hematol, Translat Med, Milan, Italy
[3] Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Gothenburg, Sweden
[4] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Clin Nutr Unit, Catanzaro, Italy
[5] Sahlgrens Univ Hosp, Div Cardiol, Gothenburg, Sweden
来源：
JOURNAL OF HEPATOLOGY | 2020年 / 73卷 / 03期
基金：
欧盟地平线“2020”; 瑞典研究理事会;
关键词：
D O I：
10.1016/j.jhep.2020.05.015
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：709 / 711
页数：3
相关论文
共 9 条
  • [1] Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker
    Baselli, Guido Alessandro
    Dongiovanni, Paola
    Rametta, Raffaela
    Meroni, Marica
    Pelusi, Serena
    Maggioni, Marco
    Badiali, Sara
    Pingitore, Piero
    Maurotti, Samantha
    Montalcini, Tiziana
    Taliento, Alice Emma
    Prati, Daniele
    Rossi, Giorgio
    Fracanzani, Anna Ludovica
    Mancina, Rosellina Margherita
    Romeo, Stefano
    Valenti, Luca
    [J]. GUT, 2020, 69 (10) : 1855 - 1866
  • [2] No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease
    Biquard, Louise
    Valla, Dominique
    Rautou, Pierre-Emmanuel
    [J]. JOURNAL OF HEPATOLOGY, 2020, 73 (03) : 717 - 718
  • [3] Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver
    Dongiovanni, P.
    Stender, S.
    Pietrelli, A.
    Mancina, R. M.
    Cespiati, A.
    Petta, S.
    Pelusi, S.
    Pingitore, P.
    Badiali, S.
    Maggioni, M.
    Mannisto, V.
    Grimaudo, S.
    Pipitone, R. M.
    Pihlajamaki, J.
    Craxi, A.
    Taube, M.
    Carlsson, L. M. S.
    Fargion, S.
    Romeo, S.
    Kozlitina, J.
    Valenti, L.
    [J]. JOURNAL OF INTERNAL MEDICINE, 2018, 283 (04) : 356 - 370
  • [4] Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study
    Ji, Dong
    Qin, Enqiang
    Xu, Jing
    Zhang, Dawei
    Cheng, Gregory
    Wang, Yudong
    Lau, George
    [J]. JOURNAL OF HEPATOLOGY, 2020, 73 (02) : 451 - 453
  • [5] Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
    Richardson, Safiya
    Hirsch, Jamie S.
    Narasimhan, Mangala
    Crawford, James M.
    McGinn, Thomas
    Davidson, Karina W.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (20): : 2052 - 2059
  • [6] UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age
    Sudlow, Cathie
    Gallacher, John
    Allen, Naomi
    Beral, Valerie
    Burton, Paul
    Danesh, John
    Downey, Paul
    Elliott, Paul
    Green, Jane
    Landray, Martin
    Liu, Bette
    Matthews, Paul
    Ong, Giok
    Pell, Jill
    Silman, Alan
    Young, Alan
    Sprosen, Tim
    Peakman, Tim
    Collins, Rory
    [J]. PLOS MEDICINE, 2015, 12 (03)
  • [7] COVID-19 and liver disease
    Sun, Jian
    Aghemo, Alessio
    Forner, Alejandro
    Valenti, Luca
    [J]. LIVER INTERNATIONAL, 2020, 40 (06) : 1278 - 1281
  • [8] Update on NAFLD genetics: From new variants to the clinic
    Trepo, Eric
    Valenti, Luca
    [J]. JOURNAL OF HEPATOLOGY, 2020, 72 (06) : 1196 - 1209
  • [9] Liver injury during highly pathogenic human coronavirus infections
    Xu, Ling
    Liu, Jia
    Lu, Mengji
    Yang, Dongliang
    Zheng, Xin
    [J]. LIVER INTERNATIONAL, 2020, 40 (05) : 998 - 1004
1